Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06633289

Hypoallergenicity of a Hydrolyzed Rice Protein-based Formula in Infants and Young Children With Cow's Milk Protein Allergy

Hypoallergenicity of a Hydrolyzed Rice Protein-based Formula in Infants and Young Children With Cow's Milk Protein Allergy: a Randomized Nutritional Clinical Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
67 (estimated)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
All
Age
60 Days – 3 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to determine whether a new hydrolyzed rice protein-based formula is hypoallergenic in infants and young children with documented Immunoglobulin E (IgE)-mediated Cow Milk Protein Allergy (CMPA).

Conditions

Interventions

TypeNameDescription
OTHERExperimental formulaNew hydrolyzed rice protein-based formula
OTHERControl formulaCommercially available amino acid-based formula.

Timeline

Start date
2024-11-05
Primary completion
2026-09-01
Completion
2026-10-01
First posted
2024-10-09
Last updated
2025-07-01

Locations

11 sites across 3 countries: Germany, Italy, Poland

Source: ClinicalTrials.gov record NCT06633289. Inclusion in this directory is not an endorsement.